A secure, unified environment connecting real-world clinical and operational data to continuous research cycles, enabling health systems and hospital networks to generate insight, improve outcomes, and advance translational science at scale.
A closed-loop data architecture that bridges routine clinical care with research analytics to accelerate bedside-to-bench discovery and evidence-based practice change.
A closed-loop data architecture that bridges routine clinical care with research analytics to accelerate bedside-to-bench discovery and evidence-based practice change.
A multi-year cohort study generating deep phenotyping datasets across the US and Canada to accelerate better clinical interventions and disease outcomes.
11 clinical sites and growing
Connecting leading research medical institutions including Mayo Clinic, Johns Hopkins University, and Brigham and Women's Hospital.
5,000 targeted participants
Tracking deep longitudinal multi-modal psychiatric data to map condition progression and uncover tailored therapeutic strategies.
Public multi-modal dataset
Released the largest multi-modal psychiatric dataset to empower the wider global scientific community
Comprehensive large-scale global collaboration designed to fast-track therapies that target LRRK2 and identify and optimize reliable biomarkers that can guide treatments.
12 international sites
Coordinating multi-centre clinical teams across Barcelona, Dundee, Lübeck, New Haven, San Francisco, San Sebastian, Sevilla, Taipei, Vienna, Kuala Lumpur, Tel Aviv, and Paris.
1,000 target cohort
Harmonizing multi-site clinical and biological biomarker datasets from 1,000 international participants under unified data governance.
3 strategic pillars
Powering open collaboration to facilitate active therapeutic programs, support LRRK2 biomarkers, and diversify therapeutic approaches.
Coordinating multi-centre clinical teams across Barcelona, Dundee, Lübeck, New Haven, San Francisco, San Sebastian, Sevilla, Taipei, Vienna, Kuala Lumpur, Tel Aviv, and Paris.
1,000 target cohort
Harmonizing multi-site clinical and biological biomarker datasets from 1,000 international participants under unified data governance.
3 strategic pillars
Powering open collaboration to facilitate active therapeutic programs, support LRRK2 biomarkers, and diversify therapeutic approaches.